Thomas Denny: Overseeing Duke’s Vaccine Research Enterprise

As chief operating officer at the Duke Human Vaccine Institute (DHVI), Thomas Denny is in the unique position of helping people fight flu and HIV, developing the next generation of COVID-19 vaccines, and all the while leading an annual 120 million enterprise.  

Read Article